Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Change in Intangibles (2022 - 2025)

Sunshine Biopharma's Change in Intangibles history spans 4 years, with the latest figure at $40998.0 for Q4 2025.

  • For Q4 2025, Change in Intangibles rose 948.82% year-over-year to $40998.0; the TTM value through Dec 2025 reached $661815.0, up 105.37%, while the annual FY2025 figure was $661815.0, 105.37% up from the prior year.
  • Change in Intangibles reached $40998.0 in Q4 2025 per SBFM's latest filing, up from $26103.0 in the prior quarter.
  • In the past five years, Change in Intangibles ranged from a high of $686044.0 in Q4 2023 to a low of -$402296.0 in Q2 2024.
  • Average Change in Intangibles over 4 years is $138533.5, with a median of $92519.0 recorded in 2024.
  • The largest YoY upside for Change in Intangibles was 4185.27% in 2024 against a maximum downside of 150.26% in 2024.
  • A 4-year view of Change in Intangibles shows it stood at $111015.0 in 2022, then soared by 517.97% to $686044.0 in 2023, then crashed by 100.7% to -$4830.0 in 2024, then soared by 948.82% to $40998.0 in 2025.
  • Per Business Quant, the three most recent readings for SBFM's Change in Intangibles are $40998.0 (Q4 2025), $26103.0 (Q3 2025), and $390187.0 (Q2 2025).